Urge the FTC to study the perverse practices of Pharmacy Benefit Managers (PBMs)

On February 24, the Federal Trade Commission (FTC) issued a solicitation for comment regarding Pharmacy Benefit Managers (PBMs) and the impact PBMs have on patients, among others. You can see the official notice here.

 Here’s what you need to know:

  • A “solicitation for comment” is just another way of saying that a federal agency is accepting input and feedback from the public.
  • The FTC is the federal agency that oversees consumer protection and other similar issues.
  • The FTC is looking at the impact PBMs have on prices, access to treatments, and beyond.
  • You can share your input directly with the FTC.

Two things you can do:

 Sign the petition below and thank you for your support!

Share your input.  You can enter your comments directly, and you can also attach documents and other materials. You can make comments until May 25, when the comment period closes.   Don’t worry about making your comments perfect, just make sure you submit them before May 25!

If you aren’t familiar with this issue, or don’t have any particular feedback to share, that’s ok. We’ll share other opportunities for you to weigh in!

Sincerely,

Rachel Derby
Executive Director of Policy and Advocacy for Patients Rising Now

Sign the Petition